#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15532	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2591	727.5	0	.	n	.	0	C1122T	SNP	1122	1122	C	1674	1674	T	992	T,C,A	513,476,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15532	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2591	727.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	2002	2002	T	1062	T,G,C	1057,4,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15532	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2591	727.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1736	1736	C	971	C,T,G	968,2,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15532	16S	1529	1529	99.87	16S.l15.c17.ctg.1	2591	727.5	0	HET	.	.	.	C226T,A	.	226	226	C	778	778	C	839	C,T,A	676,161,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27170	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3938	858.5	0	.	n	.	0	T665C	SNP	665	665	T	1214	1214	C	966	C,T,A,G	960,2,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27170	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3938	858.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1886	1886	A	1156	A	1156	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27170	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3938	858.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2520	2520	C	935	C,T,G	931,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27170	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3938	858.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2594	2594	A	906	A,G,C	904,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27170	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3938	858.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	3146	3146	C	964	C,A,T	961,2,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27170	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3938	858.5	0	HET	.	.	.	C539T,A	.	539	539	C	1088	1088	C	1019	C,T,A	757,261,1	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	27	2134	folP	852	852	99.88	folP.l15.c4.ctg.1	1986	134.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5536	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3914	176.2	1	SNP	p	S91F	0	.	.	271	273	TCC	816	818	TCC	236;235;235	T;C,G;C,T	236;234,1;234,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5536	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3914	176.2	1	SNP	p	D95G	0	.	.	283	285	GAC	828	830	GAC	239;240;240	G,T;A,C;C	238,1;239,1;240	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5536	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3914	176.2	1	SNP	p	D95N	0	.	.	283	285	GAC	828	830	GAC	239;240;240	G,T;A,C;C	238,1;239,1;240	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1870	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1927	121.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	790	792	ACC	186;185;185	A;C;C	186;185;185	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1870	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1927	121.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	988	990	CAC	222;220;220	C,T;A;C	221,1;220;220	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1870	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1927	121.1	0	.	p	.	0	K107E	NONSYN	319	321	AAA	994	996	GAA	222;221;221	G,A;A;A	221,1;221;221	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1870	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1927	121.1	1	SNP	p	G45D	0	.	.	133	135	GGC	808	810	GGC	186;191;190	G,A;G;C	185,1;191;190	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1184	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1536	95.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1756	1758	ATC	275;278;280	A;T,G;C	275;277,1;280	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1909	1911	GCA	269;271;271	G,T;C,G;A	267,1;269,1;270	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2392	2394	ATT	261;262;260	A;T,C,A;T,C	261;260,1,1;259,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	1	SNP	p	D86N	0	.	.	256	258	GAC	862	864	GAC	260;260;258	G;A,G;C,G	260;259,1;257,1	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	1	SNP	p	S87R	0	.	.	259	261	AGT	865	867	AGT	258;259;258	A;G;T,C,G,A	258;258;255,1,1,1	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	1	SNP	p	S87I	0	.	.	259	261	AGT	865	867	AGT	258;259;258	A;G;T,C,G,A	258;258;255,1,1,1	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	1	SNP	p	S87W	0	.	.	259	261	AGT	865	867	AGT	258;259;258	A;G;T,C,G,A	258;258;255,1,1,1	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	5852	parC	2304	2304	99.7	parC.l15.c4.ctg.1	3403	214.0	1	SNP	p	S88P	0	.	.	262	264	TCC	868	870	TCC	259;257;254	T,G;C;C	257,1;256;253	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4264	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3099	171.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1728	1730	GGC	229;229;224	G;G,C;C,G	229;228,1;223,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1477	1479	GCA	239;242;244	G,A;C;A	238,1;242;244	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1480	1482	ATC	244;245;241	A,G,C;T;C	242,1,1;245;241	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1492	1494	GTG	253;254;254	G,T;T,A;G	252,1;253,1;254	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1492	1494	GTG	253;254;254	G,T;T,A;G	252,1;253,1;254	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1996	1998	ACC	233;232;231	A;C,G;C	233;231,1;231	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2050	2052	GCG	225;226;226	G;C;G	225;226;226	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2050	2052	GCG	225;226;226	G;C;G	225;226;226	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2173	2175	GGT	239;236;235	G;G;T	239;236;235	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2182	2184	GGC	231;236;238	G;G;C	231;236;238	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	4162	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2856	181.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2200	2202	CCG	237;244;244	C,T;C,T;G	236,1;243,1;244	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	5710	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3522	201.9	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1841	1843	CTG	228;227;225	C;T;G,A	228;227;224,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2414	porA	1146	1146	99.65	porA.l6.c4.ctg.1	2308	130.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	825	825	C	190	C,G	189,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	S271T	NONSYN	811	813	TCG	105	107	ACT	72;72;72	A;C;T	71;71;71	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	111	113	GAT	71;71;71	G;A;T	71;71;71	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	114	116	AGT	71;71;72	A;G;T	71;71;72	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	N277H	NONSYN	829	831	AAC	123	125	CAC	72;72;72	C;A;C	72;72;72	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	213	215	GAA	4;4;4	G;A;A	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	225	227	GCA	3;3;3	G;C;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	E312D	NONSYN	934	936	GAA	228	230	GAC	3;3;3	G;A;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	234	236	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	240	242	TCG	3;2;2	T;C;G	3;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	246	248	GCC	2;2;2	G;C;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	249	251	AGC	2;2;2	A;G;C	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	252	254	GCC	2;1;1	G;C;C	2;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	326	porB1a	984	271	91.14	porB1a.l15.c4.ctg.2	409	28.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	258	260	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3070	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1889	200.1	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	969	971	CAA	253;256;258	C,G;A,C;A,C	252,1;255,1;256,2	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3070	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1889	200.1	0	.	p	.	0	E212N	NONSYN	634	636	GAA	1176	1178	AAT	285;283;284	A;A,C;T	285;282,1;284	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3070	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1889	200.1	0	.	p	.	0	H213D	NONSYN	637	639	CAT	1179	1181	GAT	284;284;276	G;A;T	284;284;276	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3070	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1889	200.1	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1185	1187	GCT	272;271;271	G;CTT,CT;T,G	272;264,1;270,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3070	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1889	200.1	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1194	1196	ATG	272;276;276	A;T;G,A	272;276;275,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3070	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1889	200.1	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1311	1313	AAG	257;258;259	A;A,C,T,G;G,C	257;255,1,1,1;257,2	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	3070	porB1b	1047	1047	99.04	porB1b.l15.c17.ctg.1	1889	200.1	1	SNP	p	G120K	0	.	.	358	360	GGC	900	902	GGC	254;252;252	G,T;G;C	253,1;252;252	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	S273T	NONSYN	817	819	TCG	52	54	ACT	66;66;66	A;C;T	66;66;66	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	D276S	NONSYN	826	828	GAT	61	63	AGT	66;66;66	A;G;T	66;66;66	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	K278D	NONSYN	832	834	AAA	67	69	GAC	66;66;66	G;A;C	66;66;66	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	R279H	NONSYN	835	837	CGC	70	72	CAC	66;66;66	C;A;C	66;66;66	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	E313A	NONSYN	937	939	GAA	172	174	GCA	1;1;1	G;C;A	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	N314D	NONSYN	940	942	AAC	175	177	GAC	1;1;1	G;A;C	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	F316I	NONSYN	946	948	TTC	181	183	ATC	1;1;1	A;T;C	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	A318S	NONSYN	952	954	GCG	187	189	TCG	1;1;1	T;C;G	1;1;1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	278	porB3	990	196	91.84	porB3.l15.c17.ctg.1	199	42.1	0	.	p	.	0	G321S	NONSYN	961	963	GGC	196	198	AGC	1;1;1	A;G;C	1;1;1	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	10656	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5330	249.1	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2229	2231	CAT	253;248;248	C,A;A,C;T	252,1;247,1;248	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1418	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1502	116.2	1	SNP	p	V57M	0	.	.	169	171	GTG	823	825	GTG	228;228;227	G;T;G,A	228;228;226,1	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
